Share 'How You Can Participate in the Ataluren Ad Comm'
The Duchenne community is now preparing for the September 28 Advisory Committee Meeting for PTC’s therapy ataluren. Whether submitting written testimony and/or attending the Ad Comm in person, there are multiple ways for Duchenne community members in the U.S. and abroad to have an impact and share your personal experience with the Advisory Committee reviewing this product.
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this